Femasys Inc. (FEMY) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Femasys Inc. on January 13, 2026. The report addresses the Company's status regarding its listing on the Nasdaq Capital Market and compliance with the Minimum Bid Price Requirement.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, or debt figures. However, it notes that the Company demonstrated stockholders' equity of more than $5 million as of December 31, 2025, to qualify for a compliance extension.
Material Changes and Listing Status
- Non-Compliance Notice: On July 16, 2025, Nasdaq notified the Company that its common stock had traded below $1.00 per share for 30 consecutive business days, violating Listing Rule 5550(a)(2).
- Initial Compliance Period: The Company had until January 12, 2026, to regain compliance.
- Extension Granted: On January 13, 2026, Nasdaq granted a 180-day extension, allowing the Company until July 13, 2026, to cure the deficiency.
Outlook, Management Commentary, and Risks
Management intends to actively monitor the closing bid price of its common stock through July 13, 2026. To regain compliance, the Company plans to effect a reverse stock split if necessary, aiming to achieve a closing bid price of at least $1.00 per share for a minimum of ten consecutive business days before the extended period expires. The primary risk remains the potential delisting if the bid price deficiency is not cured by the new deadline.
Investor Verification Checklist
- Verify the current trading price of FEMY common stock relative to the $1.00 threshold.
- Monitor for future announcements regarding the execution of a reverse stock split.
- Confirm the Company's stockholders' equity remains above $5 million to maintain eligibility for the extension.
- Track the Company's progress toward achieving ten consecutive days of trading above $1.00 prior to July 13, 2026.